Almyroudis, N. G.
Scynexis (United States)
3 papers on CoChatORCID 0000-0002-4230-3275
Most cited papers
- Verified
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityNeutropenia and Cancer Infections
Cited by 168
- Verified
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
Spec, A., Pullman, J., Thompson, G. R., Powderly, W. G., Tobin, E. H., Vazquez, J., Wring, S. A., Angulo, D., Helou, S., Pappas, P. G., et al. (2019) · Journal of Antimicrobial Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 88
- Verified
Monocyte- and Macrophage-Targeted NADPH Oxidase Mediates Antifungal Host Defense and Regulation of Acute Inflammation in Mice
Grimm, M. J., Vethanayagam, R. R., Almyroudis, N. G., Dennis, C. G., Khan, A. N. H., D’Auria, A. C., Singel, K. L., Davidson, B. A., Knight, P. R., Blackwell, T. S., et al. (2013) · The Journal of Immunology
Neutrophil, Myeloperoxidase and Oxidative MechanismsAntifungal resistance and susceptibility
Cited by 81
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free